Corporación Acciona Energías Renovables, S.A. ANE.MC
Composite 40/100; the shares have moved about 35% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 33/100 — a moderate mark against it.
Growth ranks 53/100 — a slight point in its favour.
Valuation ranks 33/100 — a moderate mark against it. Income ranks 34/100 — a moderate mark against it. Quality ranks 35/100 — a moderate mark against it.
What the company does Corporación Acciona Energías Renovables develops and operates renewable energy assets globally, spanning wind, solar, biomass, hydro, storage, green hydrogen, and mobility solutions. It also provides energy services, engineering, and decarbonization projects under Acciona’s umbrella.
Key financials ANE.MC posted ROE 11.1%, ROA 4.0%, and ROCE 7.6%, with gross, operating, and net margins of 59.2%, 20.1%, and 16.0%. Revenue fell -18.3% and EPS -32.5%, while debt/equity stands at 0.83 and net debt/EBITDA at 3.14. FCF yield is -12.0% and dividend yield 0.1%.
Stock health Sideravia scores ANE.MC 46.4 overall (average quality, attractively valued), with Quality 54.2 and Valuation 67.1. Piotroski F-Score is 7/9 and Altman Z is 1.08, indicating moderate financial health. Momentum is mixed: -2.74% over 3m but +1.91% over 6m.
Price vs fair value The stock trades at a PREMIUM of 52.90% versus our fair-value estimate of 10.23 and at a discount of 6.92% to the analyst 12-month target of 23.22. - Trading at a steep PREMIUM to fair value despite low profitability metrics (ROE 11.1%, ROA 4.0%) (Valuation percentile 67.1) - Negative FCF yield (-12.0%) and minimal dividend (0.1%) reduce income appeal (Dividend yield 0.1%) - Mixed momentum with 12m decline of -6.34% and RSI(14) at 46.40 signaling neither oversold nor overbought
Looking forward Forward P/E of 31.85 implies high growth expectations, yet recent revenue and EPS declines (-18.3%, -32.5%) challenge near-term execution. Analysts’ 23.22 target suggests upside only if growth and margin recovery materialize.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.